Teva Pharma and Trump Administration Plan Agreement on Affordable Medicines
Teva Pharma plans an agreement with the Trump Administration to align US Medicaid pricing for select medicines with leading developed markets under the GENEROUS framework.
GENErating Cost Reductions For U.S. Medicaid | 02/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy